Endovascular Stent Grafts Market Analysis 2026: Market Size, Growth Trends And Industry Outlook
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Endovascular Stent Grafts Market Size And Revenue Outlook Through 2030
The market for endovascular stent grafts has undergone considerable expansion in recent years. Its value is projected to climb from $1.45 billion in 2025 to $1.99 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 37.9%. The historical growth of this market stems from factors such as the continued reliance on traditional open surgical procedures, the restricted supply of sophisticated stent graft materials, the escalating occurrence of vascular diseases, the swift uptake of coronary and peripheral grafts, and heightened public knowledge about aortic aneurysm treatments.
The endovascular stent grafts market is projected to experience substantial growth over the coming years. Its size is anticipated to reach $7.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 37.5%. This expansion during the projection period is driven by factors such as advancements in endovascular stent graft technology, an increase in minimally invasive surgical procedures, a rise in cases of aortic aneurysm and dissection, the growing acceptance of hybrid vascular grafts, and the development of cardiovascular healthcare facilities. Key trends foreseen for this period encompass the wider embrace of minimally invasive endovascular techniques, a growing need for tailored stent grafts, innovations in hybrid and biologic graft materials, an increase in thoracic and abdominal aortic repair interventions, and a heightened emphasis on patient well-being and adherence to regulations.
Get A Free Sample Report With In-Depth Market Insights:
Endovascular Stent Grafts Market Demand Drivers Opening New Revenue Streams
The rising incidence of cardiovascular diseases is expected to propel the growth of the endovascular stent graft market going forward. Cardiovascular disease (CVD) refers to a class of diseases that involve the heart or blood vessels. The increasing prevalence of cardiovascular diseases is attributable to a combination of lifestyle choices, medical conditions, genetic predisposition, and environmental factors. Endovascular stent grafts offer a valuable option for treating cardiovascular diseases with an emphasis on minimizing invasiveness and improving patient outcomes. The stent graft reinforces the weakened vessel wall, preventing it from rupturing and reducing the risk of life-threatening complications. For instance, in October 2025, according to the Australian Institute Of Health And Welfare, an Australia-based government agency reported that in 2023, an estimated 57,100 adults aged 25 and above experienced acute coronary events, averaging roughly 156 incidents per day. Therefore, an increase in cardiovascular diseases drives the growth of endovascular stent grafts market.
Endovascular Stent Grafts Market Segment Outlook: Which Categories Are Growing Fastest?
The endovascular stent grafts market covered in this report is segmented –
1) By Product: Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts For Aorta Disease, Peripheral Vascular Grafts
2) By Raw Material: Synthetic Vascular Grafts, Biological Vascular Grafts, Hybrid Vascular Grafts
3) By Application: Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease
Subsegments:
1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts, Synthetic Hemodialysis Access Grafts, Bioengineered Hemodialysis Access Grafts, Coated Hemodialysis Grafts, Endovascular Hemodialysis Grafts
2) By Endovascular Stent Grafts: Aneurysm Stent Grafts, Stent Grafts For Aortic Dissection, Thoracic Endovascular Stent Grafts, Abdominal Endovascular Stent Grafts, Biliary Endovascular Stent Grafts
3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG), Arterial Coronary Bypass Grafts, Endovascular Coronary Artery Bypass Grafts (CABG), Synthetic Coronary Bypass Grafts
4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts, Aortic Aneurysm Grafts, Aortic Bypass Grafts, Thoracoabdominal Aortic Stent Grafts, Aortic Dissection Stent Grafts
5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts, Femoral Artery Stent Grafts, Popliteal Artery Stent Grafts, Iliac Artery Stent Grafts, Peripheral Endovascular Stent Grafts
Endovascular Stent Grafts Market Trends Powering Strategic Industry Growth
Leading companies within the endovascular stent grafts market are concentrating on developing novel products, such as the thoracic aortic stent-graft. Their objective is to enhance the accuracy and effectiveness of treating thoracic aortic aneurysms and dissections, improve patient recovery, and tackle intricate anatomical challenges through advanced technology and design upgrades. A thoracic aortic stent graft is a specialized medical implant utilized in endovascular procedures to address various diseases and conditions affecting the thoracic aorta, which is the segment of the aorta situated in the chest, providing safety, efficacy, and ease in managing thoracic aortic ailments. As an illustration, in February 2024, Endovastec, a medical device firm based in China, launched its Multi-Branch Thoracic Aortic Stent-Graft System, known as Hector, and completed its initial clinical application in Switzerland. The Hector system signifies a major stride forward in endovascular stent graft technology. Its innovative multi-branch configuration facilitates the treatment of complex thoracic aortic conditions by accommodating and safeguarding critical branches of the aorta, including those supplying vital organs.
Endovascular Stent Grafts Market Leading Companies And Competitive Benchmarking
Major companies operating in the endovascular stent grafts market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates Inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc., Endovastec Medical Technology Co Ltd., Jotec GmbH, Bentley InnoMed GmbH, Bolton Medical Inc., Alvimedica, Endospan Ltd., Vivasure Medical Ltd.
View The Full Endovascular Stent Grafts Market Report:
Endovascular Stent Grafts Market Top Region By Revenue And Market Share
North America was the largest region in the endovascular stent grafts market in 2025. The regions covered in the endovascular stent grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
